Physician profile
Mark Miceli
NPI 1881678118
$584.31
in general payments reported to CMS, 2019-2025
23 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $103 · 2021: $53.87 · 2022: $46.21 · 2023: $84.98 · 2024: $33.19 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $68.58 | 2020-2025 | Nuzyra |
| Smith+Nephew, INC. | $65.37 | 2019-2024 | Grafix Pl |
| Abbvie INC. | $37.12 | 2023-2025 | |
| Depuy Synthes Sales INC. | $36.59 | 2021 | |
| Triad Life Sciences INC. | $27.98 | 2022 | |
| Nevro Corp. | $27.26 | 2023 | Senza |
| Melinta Therapeutics, LLC | $27.11 | 2019 | |
| Progenacare Global, LLC | $25.78 | 2023 | |
| Abbott Laboratories | $25.51 | 2025 | Eterna |
| Vertex Pharmaceuticals Incorporated | $23.64 | 2025 | |
| Biowound Solutions, INC. | $23.24 | 2025 | Bio-Connekt |
| Grt US Holding, INC. | $22.07 | 2020 | |
| Zimmer Biomet Holdings, INC. | $19.08 | 2019 | |
| Alexion Pharmaceuticals, INC. | $18.79 | 2020 | |
| Mimedx Group, INC. | $18.74 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $17.28 | 2021 | |
| Orthofix Medical, INC. | $17.22 | 2023 | Physio-Stim |
| Bioventus LLC | $15.38 | 2019 | |
| Stryker Corporation | $14.85 | 2025 | Actishield Cf |
| Convatec INC. | $14.46 | 2024 | |
| Baudax Bio INC. | $13.45 | 2020 | |
| Novum Pharma, LLC | $13.16 | 2019 | |
| Hartmann USA, INC. | $11.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Miceli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.